AbstractBackgroundInvasive lobular cancer (ILC) is biologically distinct from invasive ductal cancer and there is disagreement regarding appropriate local management of this disease.AimThe current study reports long term results comparing mastectomy with breast-conserving surgery (BCS) in the treatment of ILC.Material and methodsStudy includes 235 women with ILC treated between 1983 and 1987. All of them underwent axillary dissection and either mastectomy (n=163) or BCS (n=72). 50Gy adjuvant radiotherapy (RT) was given for 53 BCS and 81 mastectomy patients. The BCS group was compared with the mastectomy group.ResultsPatients treated with mastectomy or BCS had a similar outcome at 15 years with regard to distant metastasis-free (62% vs. 70%;...
The clinical outcomes and therapeutic strategies for infiltrating ductal carcinoma (IDC) and infiltr...
In 1979, the National Cancer Institute in Bethesda, Maryland initiated a randomized, prospective tri...
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast cancer (BC):...
AbstractBackgroundInvasive lobular cancer (ILC) is biologically distinct from invasive ductal cancer...
Background Breast-conservation therapy (BCT), including wide local excision and postoperative irradi...
AbstractBackgroundThe surgical treatment of patients with invasive lobular carcinoma is still contro...
The aim of this study was to compare the frequency of breast-conserving surgery (BCS) between early-...
Purpose: The aim is to look at the impact of margin status and outcome of invasive lobular carcinoma...
9Introduction: Axillary lymph node dissection (ALND) has been considered essential for the staging o...
Previous studies of patients with breast cancer have compared survival of invasive ductal carcinoma ...
The WHO classification of breast tumors distinguishes, besides invasive breast cancer 'of no special...
The WHO classification of breast tumors distinguishes, besides invasive breast cancer 'of no special...
Background: Invasive lobular carcinoma (ILC) comprises 8-15 % of all invasive breast cancers and lar...
Background: Breast-conserving therapy (BCT) has been shown to be as effective as mastectomy in the t...
Aim of the study is to evaluate the biology, the clinical evolution and the prognosis of lobular car...
The clinical outcomes and therapeutic strategies for infiltrating ductal carcinoma (IDC) and infiltr...
In 1979, the National Cancer Institute in Bethesda, Maryland initiated a randomized, prospective tri...
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast cancer (BC):...
AbstractBackgroundInvasive lobular cancer (ILC) is biologically distinct from invasive ductal cancer...
Background Breast-conservation therapy (BCT), including wide local excision and postoperative irradi...
AbstractBackgroundThe surgical treatment of patients with invasive lobular carcinoma is still contro...
The aim of this study was to compare the frequency of breast-conserving surgery (BCS) between early-...
Purpose: The aim is to look at the impact of margin status and outcome of invasive lobular carcinoma...
9Introduction: Axillary lymph node dissection (ALND) has been considered essential for the staging o...
Previous studies of patients with breast cancer have compared survival of invasive ductal carcinoma ...
The WHO classification of breast tumors distinguishes, besides invasive breast cancer 'of no special...
The WHO classification of breast tumors distinguishes, besides invasive breast cancer 'of no special...
Background: Invasive lobular carcinoma (ILC) comprises 8-15 % of all invasive breast cancers and lar...
Background: Breast-conserving therapy (BCT) has been shown to be as effective as mastectomy in the t...
Aim of the study is to evaluate the biology, the clinical evolution and the prognosis of lobular car...
The clinical outcomes and therapeutic strategies for infiltrating ductal carcinoma (IDC) and infiltr...
In 1979, the National Cancer Institute in Bethesda, Maryland initiated a randomized, prospective tri...
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast cancer (BC):...